Molecular characterization of a suspected IMP-type carbapenemase-producing Pseudomonas aeruginosa outbreak reveals two simultaneous outbreaks in a tertiary-care hospital
To describe IMP-type carbapenemase-producing outbreaks at Galdakao University Hospital between March 2021 to December 2021. Outbreak report. Galdakao University Hospital is a tertiary-care hospital in the Basque Country (northern Spain). All patients with a positive IMP-type carbapenemase producing ...
Gespeichert in:
Veröffentlicht in: | Infection control and hospital epidemiology 2023-11, Vol.44 (11), p.1801-1808 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1808 |
---|---|
container_issue | 11 |
container_start_page | 1801 |
container_title | Infection control and hospital epidemiology |
container_volume | 44 |
creator | Gual-de-Torrella, Ana López-Causape, Carla Alejo-Cancho, Izaskun Rojo-Molinero, Estrella Sanchez-García, Gonzalo Cortés-Lara, Sara Rodríguez Moral, María B. Berdonces-Gonzalez, Pilar Lopez de Goikoetxea, María J. Oliver, Antonio |
description | To describe IMP-type carbapenemase-producing
outbreaks at Galdakao University Hospital between March 2021 to December 2021.
Outbreak report.
Galdakao University Hospital is a tertiary-care hospital in the Basque Country (northern Spain).
All patients with a positive IMP-type carbapenemase producing
(IMP-PA) culture were included in this study, both colonization and infection cases.
An outbreak investigation was conducted, in which molecular epidemiology analysis [pulsed-field gel electrophoresis and whole-genome sequencing (WGS)] and environmental screenings were performed.
Between March and December 2021, 21 cases of IMP-PA were detected in Galdakao University Hospital: 18 infection cases and 3 colonization cases. In total, 4 different pulsotypes were detected belonging to 4 clones according to WGS: ST175 (n = 14), ST633 (n = 3), ST179 (n = 3), and ST348 (n = 1). IMP-13 was detected in most isolates belonging to the ST175 clone and in all ST179 and ST348 clones, whereas IMP-29 was detected in isolates belonging to the ST633 clone. Clinical isolates belonging to the ST175 clone were isolated mainly from patients admitted to the respiratory ward, and isolates belonging to the ST633 clone from patients admitted to the ICU. Two environmental isolates belonging to the ST175 clone were detected in the respiratory ward.
Molecular and genomic epidemiology revealed that there had been 2 independent IMP-PA outbreaks, one of long duration in the respiratory ward and the other more limited in the ICU. |
doi_str_mv | 10.1017/ice.2023.75 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2809543111</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_ice_2023_75</cupid><sourcerecordid>2892292085</sourcerecordid><originalsourceid>FETCH-LOGICAL-c313t-e2eae1b02107ae10876d701cbb3141275a0d474fbbf2bc4792fc3ad935a9ed593</originalsourceid><addsrcrecordid>eNptkc1rFTEUxYNY7LO6ci8BN4LMaz5mmslSitpCS7tQcDfcZO68ps5MxnxU6n_kf9k83rMFcXXD5ZdzzuUQ8oazNWdcHTuLa8GEXKvmGVnxptHVSSvr52TFWq2rVsjvh-RljLeMMaU1f0EOpeKylY1ekT-XfkSbRwjU3kAAmzC435Ccn6kfKNCY44Jl29Pzy-sq3S9ILQQDC844QcRqCb7P1s0beh0x937yM0QKGPLGzT4C9TmZgPCDBrxDGCNNvzyNbspjghl9jo9EpG4uliVCchDuq2KE9MbHxSUYX5GDofzG1_t5RL59_vT19Ky6uPpyfvrxorKSy1ShQEBumOBMlQdr1UmvGLfGSF5zoRpgfa3qwZhBGFsrLQYrodeyAY19o-UReb_TLYf9zBhTN7locRx3YTvRMt3UknNe0Hf_oLc-h7mkK5QWQgvWNoX6sKNs8DEGHLoluKnc13HWbRvsSoPdtsFObem3e81sJuwf2b-VFaDay8Fkgus3-OT6P8EHUu6qcw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2892292085</pqid></control><display><type>article</type><title>Molecular characterization of a suspected IMP-type carbapenemase-producing Pseudomonas aeruginosa outbreak reveals two simultaneous outbreaks in a tertiary-care hospital</title><source>Cambridge Journals</source><source>ProQuest Central</source><creator>Gual-de-Torrella, Ana ; López-Causape, Carla ; Alejo-Cancho, Izaskun ; Rojo-Molinero, Estrella ; Sanchez-García, Gonzalo ; Cortés-Lara, Sara ; Rodríguez Moral, María B. ; Berdonces-Gonzalez, Pilar ; Lopez de Goikoetxea, María J. ; Oliver, Antonio</creator><creatorcontrib>Gual-de-Torrella, Ana ; López-Causape, Carla ; Alejo-Cancho, Izaskun ; Rojo-Molinero, Estrella ; Sanchez-García, Gonzalo ; Cortés-Lara, Sara ; Rodríguez Moral, María B. ; Berdonces-Gonzalez, Pilar ; Lopez de Goikoetxea, María J. ; Oliver, Antonio</creatorcontrib><description>To describe IMP-type carbapenemase-producing
outbreaks at Galdakao University Hospital between March 2021 to December 2021.
Outbreak report.
Galdakao University Hospital is a tertiary-care hospital in the Basque Country (northern Spain).
All patients with a positive IMP-type carbapenemase producing
(IMP-PA) culture were included in this study, both colonization and infection cases.
An outbreak investigation was conducted, in which molecular epidemiology analysis [pulsed-field gel electrophoresis and whole-genome sequencing (WGS)] and environmental screenings were performed.
Between March and December 2021, 21 cases of IMP-PA were detected in Galdakao University Hospital: 18 infection cases and 3 colonization cases. In total, 4 different pulsotypes were detected belonging to 4 clones according to WGS: ST175 (n = 14), ST633 (n = 3), ST179 (n = 3), and ST348 (n = 1). IMP-13 was detected in most isolates belonging to the ST175 clone and in all ST179 and ST348 clones, whereas IMP-29 was detected in isolates belonging to the ST633 clone. Clinical isolates belonging to the ST175 clone were isolated mainly from patients admitted to the respiratory ward, and isolates belonging to the ST633 clone from patients admitted to the ICU. Two environmental isolates belonging to the ST175 clone were detected in the respiratory ward.
Molecular and genomic epidemiology revealed that there had been 2 independent IMP-PA outbreaks, one of long duration in the respiratory ward and the other more limited in the ICU.</description><identifier>ISSN: 0899-823X</identifier><identifier>EISSN: 1559-6834</identifier><identifier>DOI: 10.1017/ice.2023.75</identifier><identifier>PMID: 37138359</identifier><language>eng</language><publisher>New York, USA: Cambridge University Press</publisher><subject>Antibiotics ; Antimicrobial agents ; Asthma ; Bacterial infections ; Colonization ; Coronaviruses ; COVID-19 ; Disinfection & disinfectants ; Drug resistance ; Epidemics ; Epidemiology ; Genomes ; Nosocomial infections ; Original Article ; Outbreaks ; Patients ; Pneumonia ; Primary care ; Ventilators</subject><ispartof>Infection control and hospital epidemiology, 2023-11, Vol.44 (11), p.1801-1808</ispartof><rights>The Author(s), 2023. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c313t-e2eae1b02107ae10876d701cbb3141275a0d474fbbf2bc4792fc3ad935a9ed593</cites><orcidid>0000-0003-2228-2005 ; 0000-0003-0470-418X ; 0000-0003-2214-3486</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2892292085/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2892292085?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>164,314,776,780,21367,27901,27902,33721,33722,43781,55603,74045</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37138359$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gual-de-Torrella, Ana</creatorcontrib><creatorcontrib>López-Causape, Carla</creatorcontrib><creatorcontrib>Alejo-Cancho, Izaskun</creatorcontrib><creatorcontrib>Rojo-Molinero, Estrella</creatorcontrib><creatorcontrib>Sanchez-García, Gonzalo</creatorcontrib><creatorcontrib>Cortés-Lara, Sara</creatorcontrib><creatorcontrib>Rodríguez Moral, María B.</creatorcontrib><creatorcontrib>Berdonces-Gonzalez, Pilar</creatorcontrib><creatorcontrib>Lopez de Goikoetxea, María J.</creatorcontrib><creatorcontrib>Oliver, Antonio</creatorcontrib><title>Molecular characterization of a suspected IMP-type carbapenemase-producing Pseudomonas aeruginosa outbreak reveals two simultaneous outbreaks in a tertiary-care hospital</title><title>Infection control and hospital epidemiology</title><addtitle>Infect. Control Hosp. Epidemiol</addtitle><description>To describe IMP-type carbapenemase-producing
outbreaks at Galdakao University Hospital between March 2021 to December 2021.
Outbreak report.
Galdakao University Hospital is a tertiary-care hospital in the Basque Country (northern Spain).
All patients with a positive IMP-type carbapenemase producing
(IMP-PA) culture were included in this study, both colonization and infection cases.
An outbreak investigation was conducted, in which molecular epidemiology analysis [pulsed-field gel electrophoresis and whole-genome sequencing (WGS)] and environmental screenings were performed.
Between March and December 2021, 21 cases of IMP-PA were detected in Galdakao University Hospital: 18 infection cases and 3 colonization cases. In total, 4 different pulsotypes were detected belonging to 4 clones according to WGS: ST175 (n = 14), ST633 (n = 3), ST179 (n = 3), and ST348 (n = 1). IMP-13 was detected in most isolates belonging to the ST175 clone and in all ST179 and ST348 clones, whereas IMP-29 was detected in isolates belonging to the ST633 clone. Clinical isolates belonging to the ST175 clone were isolated mainly from patients admitted to the respiratory ward, and isolates belonging to the ST633 clone from patients admitted to the ICU. Two environmental isolates belonging to the ST175 clone were detected in the respiratory ward.
Molecular and genomic epidemiology revealed that there had been 2 independent IMP-PA outbreaks, one of long duration in the respiratory ward and the other more limited in the ICU.</description><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Asthma</subject><subject>Bacterial infections</subject><subject>Colonization</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Disinfection & disinfectants</subject><subject>Drug resistance</subject><subject>Epidemics</subject><subject>Epidemiology</subject><subject>Genomes</subject><subject>Nosocomial infections</subject><subject>Original Article</subject><subject>Outbreaks</subject><subject>Patients</subject><subject>Pneumonia</subject><subject>Primary care</subject><subject>Ventilators</subject><issn>0899-823X</issn><issn>1559-6834</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNptkc1rFTEUxYNY7LO6ci8BN4LMaz5mmslSitpCS7tQcDfcZO68ps5MxnxU6n_kf9k83rMFcXXD5ZdzzuUQ8oazNWdcHTuLa8GEXKvmGVnxptHVSSvr52TFWq2rVsjvh-RljLeMMaU1f0EOpeKylY1ekT-XfkSbRwjU3kAAmzC435Ccn6kfKNCY44Jl29Pzy-sq3S9ILQQDC844QcRqCb7P1s0beh0x937yM0QKGPLGzT4C9TmZgPCDBrxDGCNNvzyNbspjghl9jo9EpG4uliVCchDuq2KE9MbHxSUYX5GDofzG1_t5RL59_vT19Ky6uPpyfvrxorKSy1ShQEBumOBMlQdr1UmvGLfGSF5zoRpgfa3qwZhBGFsrLQYrodeyAY19o-UReb_TLYf9zBhTN7locRx3YTvRMt3UknNe0Hf_oLc-h7mkK5QWQgvWNoX6sKNs8DEGHLoluKnc13HWbRvsSoPdtsFObem3e81sJuwf2b-VFaDay8Fkgus3-OT6P8EHUu6qcw</recordid><startdate>20231101</startdate><enddate>20231101</enddate><creator>Gual-de-Torrella, Ana</creator><creator>López-Causape, Carla</creator><creator>Alejo-Cancho, Izaskun</creator><creator>Rojo-Molinero, Estrella</creator><creator>Sanchez-García, Gonzalo</creator><creator>Cortés-Lara, Sara</creator><creator>Rodríguez Moral, María B.</creator><creator>Berdonces-Gonzalez, Pilar</creator><creator>Lopez de Goikoetxea, María J.</creator><creator>Oliver, Antonio</creator><general>Cambridge University Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>S0X</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2228-2005</orcidid><orcidid>https://orcid.org/0000-0003-0470-418X</orcidid><orcidid>https://orcid.org/0000-0003-2214-3486</orcidid></search><sort><creationdate>20231101</creationdate><title>Molecular characterization of a suspected IMP-type carbapenemase-producing Pseudomonas aeruginosa outbreak reveals two simultaneous outbreaks in a tertiary-care hospital</title><author>Gual-de-Torrella, Ana ; López-Causape, Carla ; Alejo-Cancho, Izaskun ; Rojo-Molinero, Estrella ; Sanchez-García, Gonzalo ; Cortés-Lara, Sara ; Rodríguez Moral, María B. ; Berdonces-Gonzalez, Pilar ; Lopez de Goikoetxea, María J. ; Oliver, Antonio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c313t-e2eae1b02107ae10876d701cbb3141275a0d474fbbf2bc4792fc3ad935a9ed593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Asthma</topic><topic>Bacterial infections</topic><topic>Colonization</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Disinfection & disinfectants</topic><topic>Drug resistance</topic><topic>Epidemics</topic><topic>Epidemiology</topic><topic>Genomes</topic><topic>Nosocomial infections</topic><topic>Original Article</topic><topic>Outbreaks</topic><topic>Patients</topic><topic>Pneumonia</topic><topic>Primary care</topic><topic>Ventilators</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gual-de-Torrella, Ana</creatorcontrib><creatorcontrib>López-Causape, Carla</creatorcontrib><creatorcontrib>Alejo-Cancho, Izaskun</creatorcontrib><creatorcontrib>Rojo-Molinero, Estrella</creatorcontrib><creatorcontrib>Sanchez-García, Gonzalo</creatorcontrib><creatorcontrib>Cortés-Lara, Sara</creatorcontrib><creatorcontrib>Rodríguez Moral, María B.</creatorcontrib><creatorcontrib>Berdonces-Gonzalez, Pilar</creatorcontrib><creatorcontrib>Lopez de Goikoetxea, María J.</creatorcontrib><creatorcontrib>Oliver, Antonio</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Infection control and hospital epidemiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gual-de-Torrella, Ana</au><au>López-Causape, Carla</au><au>Alejo-Cancho, Izaskun</au><au>Rojo-Molinero, Estrella</au><au>Sanchez-García, Gonzalo</au><au>Cortés-Lara, Sara</au><au>Rodríguez Moral, María B.</au><au>Berdonces-Gonzalez, Pilar</au><au>Lopez de Goikoetxea, María J.</au><au>Oliver, Antonio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular characterization of a suspected IMP-type carbapenemase-producing Pseudomonas aeruginosa outbreak reveals two simultaneous outbreaks in a tertiary-care hospital</atitle><jtitle>Infection control and hospital epidemiology</jtitle><addtitle>Infect. Control Hosp. Epidemiol</addtitle><date>2023-11-01</date><risdate>2023</risdate><volume>44</volume><issue>11</issue><spage>1801</spage><epage>1808</epage><pages>1801-1808</pages><issn>0899-823X</issn><eissn>1559-6834</eissn><abstract>To describe IMP-type carbapenemase-producing
outbreaks at Galdakao University Hospital between March 2021 to December 2021.
Outbreak report.
Galdakao University Hospital is a tertiary-care hospital in the Basque Country (northern Spain).
All patients with a positive IMP-type carbapenemase producing
(IMP-PA) culture were included in this study, both colonization and infection cases.
An outbreak investigation was conducted, in which molecular epidemiology analysis [pulsed-field gel electrophoresis and whole-genome sequencing (WGS)] and environmental screenings were performed.
Between March and December 2021, 21 cases of IMP-PA were detected in Galdakao University Hospital: 18 infection cases and 3 colonization cases. In total, 4 different pulsotypes were detected belonging to 4 clones according to WGS: ST175 (n = 14), ST633 (n = 3), ST179 (n = 3), and ST348 (n = 1). IMP-13 was detected in most isolates belonging to the ST175 clone and in all ST179 and ST348 clones, whereas IMP-29 was detected in isolates belonging to the ST633 clone. Clinical isolates belonging to the ST175 clone were isolated mainly from patients admitted to the respiratory ward, and isolates belonging to the ST633 clone from patients admitted to the ICU. Two environmental isolates belonging to the ST175 clone were detected in the respiratory ward.
Molecular and genomic epidemiology revealed that there had been 2 independent IMP-PA outbreaks, one of long duration in the respiratory ward and the other more limited in the ICU.</abstract><cop>New York, USA</cop><pub>Cambridge University Press</pub><pmid>37138359</pmid><doi>10.1017/ice.2023.75</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-2228-2005</orcidid><orcidid>https://orcid.org/0000-0003-0470-418X</orcidid><orcidid>https://orcid.org/0000-0003-2214-3486</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0899-823X |
ispartof | Infection control and hospital epidemiology, 2023-11, Vol.44 (11), p.1801-1808 |
issn | 0899-823X 1559-6834 |
language | eng |
recordid | cdi_proquest_miscellaneous_2809543111 |
source | Cambridge Journals; ProQuest Central |
subjects | Antibiotics Antimicrobial agents Asthma Bacterial infections Colonization Coronaviruses COVID-19 Disinfection & disinfectants Drug resistance Epidemics Epidemiology Genomes Nosocomial infections Original Article Outbreaks Patients Pneumonia Primary care Ventilators |
title | Molecular characterization of a suspected IMP-type carbapenemase-producing Pseudomonas aeruginosa outbreak reveals two simultaneous outbreaks in a tertiary-care hospital |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T23%3A03%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20characterization%20of%20a%20suspected%20IMP-type%20carbapenemase-producing%20Pseudomonas%20aeruginosa%20outbreak%20reveals%20two%20simultaneous%20outbreaks%20in%20a%20tertiary-care%20hospital&rft.jtitle=Infection%20control%20and%20hospital%20epidemiology&rft.au=Gual-de-Torrella,%20Ana&rft.date=2023-11-01&rft.volume=44&rft.issue=11&rft.spage=1801&rft.epage=1808&rft.pages=1801-1808&rft.issn=0899-823X&rft.eissn=1559-6834&rft_id=info:doi/10.1017/ice.2023.75&rft_dat=%3Cproquest_cross%3E2892292085%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2892292085&rft_id=info:pmid/37138359&rft_cupid=10_1017_ice_2023_75&rfr_iscdi=true |